Comparison of preoperative locoregional Ga-68 PSMA-11 PET-CT and mp-MRI results with postoperative histopathology of prostate cancer
- PMID: 31012125
- DOI: 10.1002/pros.23812
Comparison of preoperative locoregional Ga-68 PSMA-11 PET-CT and mp-MRI results with postoperative histopathology of prostate cancer
Abstract
Background: Conventional imaging modalities are inadequate to evaluate locoregional extension of prostate cancer (PCa). The aim of the current retrospective study was to investigate the diagnostic efficacy of Gallium-68 prostate-specific membrane antigen-11 (Ga-68 PSMA-11) positron emission tomography/computed tomography (PET/CT) and multiparametric magnetic resonance imaging (mp-MRI) for staging preoperative PCa patients with correlating histopathology.
Materials and methods: Twenty-four patients with histologically proven PCa underwent both Ga-68 PSMA-11 PET/CT and mp-MRI before robot-assisted laparoscopic radical prostatectomy. For each tumor area, correlations with histopathological results were defined for tumor localization, extraprostatic extension (EPE) of the tumor, invasion of seminal vesicle (SVI) and bladder neck invasion (BNI). In patients with regional lymph node (LN) dissection, histopathological results were also correlated with imaging modalities.
Results: Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy for detection of EPE and SVI were higher for mp-MRI than Ga-68 PSMA-11 PET/CT. On the other hand Ga-68 PSMA-11 PET/CT had significant successful results for detection of LN metastases when compared with mp-MRI. But for BNI detection both modalities had same insufficient results. Ga-68 PSMA-11 PET/CT had strong results for appropriate tumor localization in the gland.
Conclusion: Ga-68 PSMA PET/CT has superior results for assessing local LN metastases and for intraprostatic tumor localization. Whereas, mp-MRI must be the preferred modality for determining SVI and EPE. But both imaging modalities failed for determining BNI accurately. Both modalities should be used in conjunction with each other for better treatment planning.
Keywords: Gallium-68 prostate-specific membrane antigen-11 positron emission tomography/computed tomography; extraprostatic extension; lymph node; multiparametric magnetic resonance imaging; prostate cancer; seminal vesicle.
© 2019 Wiley Periodicals, Inc.
Similar articles
-
Comparison of 68Ga-PSMA-I/T PET-CT and Multiparametric MRI for Locoregional Staging of Prostate Cancer Patients: A Pilot Study.Urol Int. 2020;104(9-10):684-691. doi: 10.1159/000509974. Epub 2020 Aug 4. Urol Int. 2020. PMID: 32750695
-
Head-to-head comparison of GA-68 PSMA PET/CT and multiparametric MRI findings with postoperative results in preoperative locoregional staging and localization of prostate cancer.Prostate. 2025 Jan;85(1):48-57. doi: 10.1002/pros.24799. Epub 2024 Sep 30. Prostate. 2025. PMID: 39345022 Free PMC article.
-
Comparison of 68Ga-PSMA PET/CT and mp-MRI in regard to local staging for prostate cancer with histopathological results: A retrospective study.Prostate. 2022 Nov;82(15):1462-1468. doi: 10.1002/pros.24420. Epub 2022 Aug 1. Prostate. 2022. PMID: 35915579
-
68Ga-Labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography for Prostate Cancer: A Systematic Review and Meta-analysis.Eur Urol Focus. 2018 Sep;4(5):686-693. doi: 10.1016/j.euf.2016.11.002. Epub 2016 Nov 15. Eur Urol Focus. 2018. PMID: 28753806
-
Use of gallium-68 prostate-specific membrane antigen positron-emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literature.BJU Int. 2020 Feb;125(2):206-214. doi: 10.1111/bju.14944. Epub 2019 Nov 29. BJU Int. 2020. PMID: 31680398 Free PMC article. Review.
Cited by
-
Preliminary Results of an Ongoing Prospective Clinical Trial on the Use of 68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Staging of High-Risk Prostate Cancer Patients.Diagnostics (Basel). 2021 Nov 9;11(11):2068. doi: 10.3390/diagnostics11112068. Diagnostics (Basel). 2021. PMID: 34829417 Free PMC article.
-
PSMA PET for primary lymph node staging of intermediate and high-risk prostate cancer: an expedited systematic review.Cancer Imaging. 2020 Jan 23;20(1):10. doi: 10.1186/s40644-020-0290-9. Cancer Imaging. 2020. PMID: 31973751 Free PMC article.
-
Prostate-specific membrane antigen positron emission tomography (PSMA-PET) for local staging of prostate cancer: a systematic review and meta-analysis.Eur J Hybrid Imaging. 2020 Sep 9;4(1):16. doi: 10.1186/s41824-020-00085-9. Eur J Hybrid Imaging. 2020. PMID: 34191215 Free PMC article.
-
Head-to-head comparison of prostate-specific membrane antigen PET and multiparametric MRI in the diagnosis of pretreatment patients with prostate cancer: a meta-analysis.Eur Radiol. 2024 Jun;34(6):4017-4037. doi: 10.1007/s00330-023-10436-2. Epub 2023 Nov 20. Eur Radiol. 2024. PMID: 37981590 Review.
-
The Diagnostic Value of High-Resolution Computed Tomography Features Combined with Mycoplasma Pneumoniae Ribonucleic Acid Load Detection for Refractory Mycoplasma Pneumonia.Contrast Media Mol Imaging. 2022 May 4;2022:6460865. doi: 10.1155/2022/6460865. eCollection 2022. Contrast Media Mol Imaging. 2022. PMID: 35601566 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous